Jr. John Lee Welborn - Net Worth and Insider Trading
Jr. John Lee Welborn Net Worth
The estimated net worth of Jr. John Lee Welborn is at least $310,400 dollars as of 2024-09-23. Jr. John Lee Welborn is the Director of HLS Therapeutics Inc and owns about 97,000 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $310,400. Details can be seen in Jr. John Lee Welborn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jr. John Lee Welborn has not made any transactions after 2023-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jr. John Lee Welborn
Jr. John Lee Welborn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jr. John Lee Welborn owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .
Click here to see the complete history of Jr. John Lee Welborn’s form 4 insider trades.
Insider Ownership Summary of Jr. John Lee Welborn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2023-06-08 | Director |
Jr. John Lee Welborn Latest Holdings Summary
Jr. John Lee Welborn currently owns a total of 1 stock. Jr. John Lee Welborn owns 97,000 shares of HLS Therapeutics Inc (TSX:HLS) as of June 8, 2023, with a value of $310,400.
Latest Holdings of Jr. John Lee Welborn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2023-06-08 | 97,000 | 3.20 | 310,400 |
Holding Weightings of Jr. John Lee Welborn
Jr. John Lee Welborn Form 4 Trading Tracker
According to the SEC Form 4 filings, Jr. John Lee Welborn has made a total of 1 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in HLS Therapeutics Inc is the acquisition of 97,000 shares on June 8, 2023, which cost Jr. John Lee Welborn around $417,100.
Insider Trading History of Jr. John Lee Welborn
- 1
Jr. John Lee Welborn Trading Performance
GuruFocus tracks the stock performance after each of Jr. John Lee Welborn's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by Jr. John Lee Welborn is -22.83%. GuruFocus also compares Jr. John Lee Welborn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jr. John Lee Welborn within 1 year outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jr. John Lee Welborn's insider trading performs compared to the benchmark.
Performance of Jr. John Lee Welborn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.25 | | | | | |
| Relative Return to S&P 500(%) | 31.8 | | | | | |
Jr. John Lee Welborn Ownership Network
Jr. John Lee Welborn Owned Company Details
What does HLS Therapeutics Inc do?
Who are the key executives at HLS Therapeutics Inc?
Jr. John Lee Welborn is the Director of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , Senior Officer Brian Thomas Walsh , and 10% Security Holder Polar Asset Management Partners Inc. .
HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary
Over the past 18 months, Jr. John Lee Welborn made 1 insider transaction in HLS Therapeutics Inc (TSX:HLS) with a net purchase of 97,000. Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 12,500 shares made by Craig Millian , and a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. .
In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.
HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
HLS Therapeutics Inc Insider Transactions
Jr. John Lee Welborn Mailing Address
Above is the net worth, insider trading, and ownership report for Jr. John Lee Welborn. Currently GuruFocus does not have mailing address information for Jr. John Lee Welborn.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
